Former Evalve CEO Ferolyn Powell, who led the MitraClip developer to a $410 million acquisition by Abbott (NYSE:ABT), died this month in a motorbike accident in northern Thailand, her family said yesterday.
Cantel Medical Corp.
Cantel Medical to pay $27M for endoscope reprocessor PuriCore
Cantel Medical (NYSE:CMN) said it agreed to put up $26.9 million in cash to acquire PuriCore International, a British endoscope reprocessing company.
Cantel Medical slides despite Street-beating Q2
Cantel Medical (NYSE:CMN) shares are down nearly 4% this morning after the medical device company reported its fiscal 2nd-quarter results.
Cantel boosts sterility business with Sterilator acquisition
Cantel Medical (NYSE:CMN) acquired Sterilator Co. for an undisclosed sum through its Crosstex subsidiary, the companies announced this month.
Sterilator manufactures biological indicators and supplies for sterility assurance products. Cantel Hauppauge, N.Y.-based Crosstex focuses on sterility assurance products and was bought out by Cantel in 2005.
Cantel Medical acquires Jet Prep in closed-doors deal
Cantel Medical (NYSE:CMN) today announced the acquisition of Jet Prep Ltd, an endoscopy device company based in Herzliya, Israel.
Jet Prep is the developer of the Jet Prep Flushing Device, an endoscopic tool used for washing mucosal tissue in the gastrointestinal tract which already has regulatory clearances for the U.S. and E.U. markets.
Cantel Medical buys Siemens’ dialysis water purification business
Cantel Medical (NYSE:CMN) said its Mar Cor subsidiary bought Siemens‘ (NYSE:SI) hemodialysis water purification unit for an undisclosed amount, part of its campaign to acquire water purification and infection control businesses across North America.
Amgen mourns death of founder George Rathmann | Personnel Moves
Medical Device Tax: Ten companies in line for a whack
The medical device tax set to take effect next year as part of the Affordable Care Act will see all medical device companies pay a 2.3% levy on U.S. sales. But the tax is likely to strike some companies a lot harder where it hurts the most: the bottom line.
Biolase CEO Pignatelli touts $1 salary | Earnings Roundup
Biolase Technology (NSDQ:BLTI) CEO Federico Pignatelli agreed to another year at a $1 salary as the dental laser maker met Wall Street’s 4th-quarter forecast with a whopping 35% top-line bump.
Pignatelli set his annual pay package at $1 and 35,000 shares of BLTI stock when he took the role of vice chairman in July 2010, a month after he was terminated as president, SEC filings show.
Ortho stocks up on strong Q2 prelims for Biomet | Earnings Roundup
Shares of orthopedic device makers are up this morning after bellwether Biomet Inc. reported preliminary sales numbers indicating 3.8% growth for its fiscal second quarter.
Former Minntech CEO Malkin back on the job | Personnel Moves
Roy Malkin, the former CEO of Minntech Corp. who was seriously injured last spring in a plane crash, has been back with the company on a limited basis since September, according to a regulatory filing.
Malkin’s private single-jet plane crashed in early June in Crystal, Minn., as the plane was attempting to take off.
